https://www.selleckchem.com/pr....oducts/3-aminobenzam
BACKGROUND In France, most patients with opioid use disorder (OUD) have been treated by buprenorphine, prescribed by general practitioners (GP) in private practice since 1996. This has contributed to building a 'French model' facilitating access to treatment based on the involvement of GPs in buprenorphine prescription. OBJECTIVES Our study aimed to assess whether the involvement of primary care in OUD management has changed lately. MATERIALS AND METHODS Using data from the French National Health Insurance database, we conducte
پسند
تبصرہ
بانٹیں
